Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease (TRAMPOLINE)
2024-512544-27-00Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiloride in autosomal dominant polycystic kidney disease (ADPKD) (2 arms), sponsored by Erasmus MC. Started May 2024; status: completed.
02
Drugs
amiloride
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on 2024-512544-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512544-27-00.